跳至主要内容
临床试验/NCT02863588
NCT02863588终止不适用

Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis

University Hospital, Strasbourg, France2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2017年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
16
试验地点
2
主要终点
Highlighting of genetic mutations associated with the susceptibility to Toxoplasma gondii.severe eye recurrences. Mutation analysis will be done by exome sequencing of the subjects included in this study

研究概览

简要总结

Ocular toxoplasmosis (OT) is a major cause of visual impairment worldwide. OT is responsible for 30 to 50% of posterior uveitis. It is characterized by dormant infections that may reactivate without known reasons, causing severe irreversible visual loss. The overall recurrence rate of OT in Europe is greater than 80% for patients and may range from one episode to 11 episodes (1% of OT) in the most extreme cases. Current treatments do not reduce the risk of recurrences and the risk of toxoplasmosis recurrence cannot be predicted in these immunocompetent patients. These clinical and biological expression changes might be related to an individual genetic susceptibility of each patient. The advanced analysis of the entire genome now possible to consider the project.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • seropositive for Toxoplasma gondii (for patient and parents)
  • Infection with genotype II (for patient and parents)
  • ocular toxoplasmosis recurrences >5 (patients only)

排除标准

  • Parents seronegative for T. gondii infection
  • Infection with others genotypes than type II

结局指标

主要结局

Highlighting of genetic mutations associated with the susceptibility to Toxoplasma gondii.severe eye recurrences. Mutation analysis will be done by exome sequencing of the subjects included in this study

时间窗: This analysis will be performed on a blood sample taken in patients included in the inclusion visit

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验